A short-term chick embryo
Cancer stem cells
Xenograft model
chick embryo
metastasis
retinoblastoma
Journal
Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
entrez:
3
5
2022
pubmed:
4
5
2022
medline:
6
5
2022
Statut:
ppublish
Résumé
Cancer stem cells (CSCs) reported in various tumors play a crucial role in tumorigenesis and metastasis of retinoblastoma (Rb). Following the efforts to reduce, replace, and refine the use of mammalian models, we aimed to establish a short-term xenograft for Rb to evaluate the CSC properties of CD133 Y79 cells were cultured, labeled with two different dyes (CM-Dil Y79 and enhanced green fluorescent protein (eGFP)) and sorted for CD133 Y79 cells formed pink-white raised perivascular nodules with feeder vessels on the CAM with both the types of labeled CD133 This study highlights that CE-CAM is a feasible alternative nonmammalian model for evaluating tumorigenicity and metastatic potential of Y79 CSCs. Increased tumorigenicity and metastatic potential of CD133
Identifiants
pubmed: 35502056
pii: IndianJOphthalmol_2022_70_5_1703_343968
doi: 10.4103/ijo.IJO_2348_21
pmc: PMC9332960
doi:
Substances chimiques
AC133 Antigen
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1703-1711Commentaires et corrections
Type : CommentIn
Déclaration de conflit d'intérêts
None
Références
PLoS One. 2016 Sep 14;11(9):e0163025
pubmed: 27626280
Ocul Oncol Pathol. 2015 Apr;1(3):207-13
pubmed: 27171579
J Vis Exp. 2011 May 30;(51):
pubmed: 21673636
Cancer. 2000 Nov 15;89(10):2117-21
pubmed: 11066053
Pediatr Clin North Am. 2015 Feb;62(1):201-23
pubmed: 25435120
Oncol Rep. 2018 Jan;39(1):160-172
pubmed: 29192327
PLoS One. 2019 Apr 15;14(4):e0215312
pubmed: 30986223
Biochim Biophys Acta Rev Cancer. 2019 Jan;1871(1):50-63
pubmed: 30419314
Oncogenesis. 2015 Feb 09;4:e138
pubmed: 25664931
Oncogenesis. 2012 Aug 27;1:e24
pubmed: 23552815
Exp Cell Res. 2014 Nov 1;328(2):314-24
pubmed: 24972385
Cancers (Basel). 2020 Aug 16;12(8):
pubmed: 32824373
J Nucl Med. 2013 Oct;54(10):1782-8
pubmed: 23970367
Mol Aspects Med. 2014 Oct;39:82-101
pubmed: 23831316
J Exp Med. 1913 Apr 1;17(4):482-93
pubmed: 19867659
Indian J Ophthalmol. 2020 Nov;68(11):2356-2365
pubmed: 33120616
Mol Vis. 2005 Sep 12;11:729-37
pubmed: 16179903
Nat Rev Dis Primers. 2015 Aug 27;1:15021
pubmed: 27189421
Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1506-14
pubmed: 19029022
BMC Cancer. 2017 Nov 21;17(1):779
pubmed: 29162051
Invest Ophthalmol Vis Sci. 2021 Nov 1;62(14):13
pubmed: 34784412
Semin Cancer Biol. 2020 Feb;60:148-156
pubmed: 31521746
Ocul Oncol Pathol. 2015 Apr;1(3):133-40
pubmed: 27171889
Trends Mol Med. 2016 Oct;22(10):863-876
pubmed: 27567287
Biochem Pharmacol. 2014 Jan 1;87(1):150-61
pubmed: 23817077
Histochem Cell Biol. 2015 Mar;143(3):325-38
pubmed: 25326674
Mech Dev. 2016 Aug;141:70-77
pubmed: 27178379
Br J Cancer. 2006 Jun 19;94(12):1845-52
pubmed: 16721359
Saudi J Ophthalmol. 2013 Jul;27(3):141-6
pubmed: 24227978
Sci Rep. 2015 Jul 14;5:10351
pubmed: 26169357
Interface Focus. 2013 Jun 6;3(3):20130001
pubmed: 23853708
Stem Cells. 2011 Sep;29(9):1391-404
pubmed: 21774040